Oncopeptides AB(GB:0RN4)
kr 1.72-0.05 (-3.05%)
GB:0RN4
Oncopeptides AB financials statements
kr 1.72
At close:-0.05 (-3.05%)
Oncopeptides AB (0RN4) Financial Statements
2 Followers
Oncopeptides AB Financial Overview
Oncopeptides AB's market cap is currently kr759.19M. The company's EPS TTM is kr-0.63; its P/E ratio is -2.78; Oncopeptides AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 71.12M | kr 31.65M | kr 35.22M | kr 8.36M | kr 118.30M |
| Gross Profit | kr 59.00M | kr 28.98M | kr 36.30M | kr 8.35M | kr 65.17M |
| Operating Income | kr -225.89M | kr -283.50M | kr -253.45M | kr -349.35M | kr -1.42B |
| EBITDA | kr -219.26M | kr -261.81M | kr -231.62M | kr -319.64M | kr -1.41B |
| Net Income | kr -249.59M | kr -284.61M | kr -249.11M | kr -337.95M | kr -1.43B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 82.25M | kr 178.54M | kr 173.44M | kr 344.51M | kr 364.30M |
| Total Assets | kr 134.84M | kr 244.19M | kr 238.38M | kr 385.32M | kr 439.38M |
| Total Debt | kr 139.39M | kr 141.72M | kr 126.16M | kr 9.54M | kr 14.19M |
| Net Debt | kr 57.13M | kr -36.82M | kr -47.25M | kr -334.97M | kr -347.99M |
| Total Liabilities | kr 193.73M | kr 189.91M | kr 181.60M | kr 91.03M | kr 228.51M |
| Stockholders' Equity | kr -58.89M | kr 54.28M | kr 56.78M | kr 294.29M | kr 210.87M |
| Cash Flow | |||||
| Free Cash Flow | kr -222.88M | kr -260.57M | kr -279.61M | kr -423.02M | kr -1.52B |
| Operating Cash Flow | kr -222.88M | kr -260.57M | kr -279.49M | kr -420.51M | kr -1.52B |
| Investing Cash Flow | kr 0.00 | kr 496.00K | kr -116.00K | kr -2.51M | kr -339.00K |
| Financing Cash Flow | kr 128.55M | kr 263.81M | kr 106.89M | kr 392.40M | kr 1.03B |
Currency in SEK
